Profund Advisors’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $298K | Buy |
17,088
+1,264
| +8% | +$22.1K | 0.01% | 695 |
|
|
2025
Q1 | $199K | Sell |
15,824
-11,046
| -41% | -$139K | 0.01% | 908 |
|
|
2024
Q4 | $283K | Buy |
26,870
+10,467
| +64% | +$110K | 0.01% | 796 |
|
|
2024
Q3 | $238K | Buy |
16,403
+274
| +2% | +$3.97K | 0.01% | 955 |
|
|
2024
Q2 | $137K | Sell |
16,129
-1,303
| -7% | -$11.1K | 0.01% | 1025 |
|
|
2024
Q1 | $178K | Buy |
+17,432
| New | +$178K | 0.01% | 1090 |
|